MICHIGAN CRITICAL CARE CONSULTANTS, INC.
Dexter, MI · Founded 2013 · CIK 0001656918 · Medtech · Acquired
Femoral dual-lumen cannula with echogenic material for extracorporeal life support (ECLS) initiation
mc3corp.com →- Grants
- $7.6M
- 7 awards
- Sector median: 1
- Raised
- $34M
- 1 Form D · Nov 2015
- 130 months since last filing
- Contracts
- $849K
- 1 award · Defense
- #337 of 4531 in medtech
- Patents
- 6
- 4 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓200820102012201420162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Defense · SBIR Phase I | $848,678 | |
| Federal grant | Department of Health and Human Services · Phase II · Artificial Placenta Device | $1,264,354 | |
| Federal grant | Department of Health and Human Services · Phase II · Commercialization of a Simple Automatic Perfusion System for ECPR | $2,478,599 | |
| Private capital raised | Form D · SEC | $34,000,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Cardiac Ventricular Assist Catheter | $209,536 | |
| Federal grant | Department of Health and Human Services · Phase II · Cardiac Ventricular Assist Catheter | $1,490,255 | |
| Federal grant | Department of Health and Human Services · Phase I · Pediatric ECMO Oxygenator with Integrated Monitoring | $223,362 | |
| Federal grant | Department of Health and Human Services · Phase II · Pediatric ECMO Oxygenator with Integrated Monitoring | $1,658,070 | |
| Federal grant | Department of Defense · Phase I · Ultrasonic-Guided Femoral Dual Lumen Cannula for Veno-Venous Extracorporeal Life Support | $249,999 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 334 | LIM INNOVATIONS, INC. | $892K | $11M |
| 335 | Tissuevision Inc | $880K | — |
| 336 | OCT MEDICAL IMAGING, INC. | $850K | — |
| 337 | MICHIGAN CRITICAL CARE CONSULTANTS, INC. | $849K | $34M |
| 338 | MEMSEL INC. | $844K | — |
| 339 | EASEALERT LLC | $842K | $200K |
| 340 | EVOGEN, INC. | $841K | $1.9M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Christopher BallDirector
- Robert BartlettDirector
- Rio FosterDirector
- Robert FosterDirector · Executive Officer
- Scott MerzDirector · Executive Officer
- Catherine SchmidtExecutive Officer
- William SidorDirector
Patents
- Devices and Methods for Extracorporeal Conditioning of Bloodgranted
- Membrane Oxygenator with Gas Exchange Fiber Lumen Access Based on Fiber Effective Lengthgranted
- Catheters for Extracorporeal Circulationgranted
- Devices And Methods For Extracorporeal Conditioning Of Bloodgranted
- Apparatus And Method For Monitoring And Controlling Extracorporeal Blood Flow Relative To Patient Fluid Statusapplication
- Pulsatile Rotary Ventricular Pumpapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.